T Shikata

Author PubWeight™ 112.59‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Staining methods of Australia antigen in paraffin section--detection of cytoplasmic inclusion bodies. Jpn J Exp Med 1974 3.08
2 Hepatitis B e antigen and infectivity of hepatitis B virus. J Infect Dis 1977 2.80
3 Inflammatory pseudotumor of the liver. Clinicopathologic study and review of the literature. Cancer 1990 2.26
4 Complete nucleotide sequence of a hepatitis E virus isolated from the Xinjiang epidemic (1986-1988) of China. Nucleic Acids Res 1992 1.89
5 Rapamycin causes poorly reversible inhibition of mTOR and induces p53-independent apoptosis in human rhabdomyosarcoma cells. Cancer Res 1999 1.89
6 Susceptibility of hepatitis B virus to disinfectants or heat. J Clin Microbiol 1984 1.70
7 The dilute-lethal (dl) gene attacks a Ca2+ store in the dendritic spine of Purkinje cells in mice. Neurosci Lett 1996 1.69
8 Changes in the transplanted ureter. Br J Exp Pathol 1965 1.50
9 Studies on the mechanism of resistance to rapamycin in human cancer cells. Mol Pharmacol 1998 1.41
10 Alloimmune neonatal neutropenia in monozygous twins. High-dose intravenous gammaglobulin therapy. Acta Paediatr Scand 1991 1.39
11 Light microscopic localization of hepatitis B virus antigens in the human pancreas. Possibility of multiplication of hepatitis B virus in the human pancreas. Gastroenterology 1981 1.38
12 Serial transmission of a putative causative virus of enterically transmitted non-A, non-B hepatitis to Macaca fascicularis and Macaca mulatta. Jpn J Exp Med 1990 1.34
13 Production of antibody associated with non-A, non-B hepatitis in a chimpanzee lymphoblastoid cell line established by in vitro transformation with Epstein-Barr virus. Proc Natl Acad Sci U S A 1985 1.32
14 Sequence and gene structure of the hepatitis E virus isolated from Myanmar. Virus Genes 1993 1.30
15 Isolated dissection of the celiac artery--a case report. Angiology 2000 1.26
16 p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin. Cancer Res 2001 1.26
17 Occurrence and character of a putative causative virus of enterically-transmitted non-A, non-B hepatitis in bile. Jpn J Exp Med 1990 1.25
18 Three different patterns of hepatitis C virus infection in chimpanzees. Hepatology 1992 1.21
19 Detection of hepatitis A antigen in human liver. Infect Immun 1982 1.15
20 Further studies by immunofluorescence of the monoclonal antibodies associated with experimental non-A, non-B hepatitis in chimpanzees and their relation to D hepatitis. Hepatology 1987 1.11
21 Incomplete inactivation of hepatitis B virus after heat treatment at 60 C for 10 hours. J Infect Dis 1978 1.08
22 Australia antigen in liver tissue--an immunofluorescent and immunoelectron microscopic study. Jpn J Exp Med 1973 1.06
23 Mother-to-child transmission of hepatitis C virus. J Infect Dis 1991 1.03
24 Hematocrit as a risk factor of cerebral infarction: long-term prospective population survey in a Japanese rural community. Stroke 1986 1.02
25 Localization of hepatitis B surface and core antigens in human hepatocellular carcinoma by immunoperoxidase methods. Replication of complete virions of carcinoma cells. Cancer 1985 1.02
26 Nucleotide sequence of hepatitis B virus isolated from subjects without serum anti-hepatitis B core antibody. J Med Virol 1995 0.99
27 N-Myc induction stimulated by insulin-like growth factor I through mitogen-activated protein kinase signaling pathway in human neuroblastoma cells. Cancer Res 2000 0.98
28 Molecular cloning and sequence analysis of duck hepatitis B virus genomes of a new variant isolated from Shanghai ducks. Virology 1989 0.98
29 Squamous cell carcinoma of gallbladder--report of two cases and review of literature. Acta Pathol Jpn 1981 0.96
30 Clonal origin of human hepatoma determined by integration of hepatitis B virus DNA. Cancer Res 1986 0.96
31 Detection of hepatitis C virus antibodies and hepatitis C virus RNA in patients with alcoholic liver disease. Hepatology 1991 0.95
32 Diffuse bilateral thalamic astrocytomas as examined serially by MRI. Childs Nerv Syst 1998 0.94
33 Experimental vaccine activities of recombinant E1 and E2 glycoproteins and hypervariable region 1 peptides of hepatitis C virus in chimpanzees. Arch Virol 1999 0.93
34 Drug-induced generalized phospholipidosis. Acta Pathol Jpn 1972 0.93
35 Sequence comparison of the capsid region of hepatitis E viruses isolated from Myanmar and China. Microbiol Immunol 1992 0.93
36 Evolution of the hepatitis B virus gene during chronic infection in seven patients. J Med Virol 1994 0.93
37 Enzyme-altered liver cell foci in woodchucks infected with woodchuck hepatitis virus. Jpn J Cancer Res 1988 0.91
38 HCV in saliva of chronic hepatitis patients having dental treatment. Lancet 1991 0.91
39 Production of antibodies directed against microtubular aggregates in hepatocytes of chimpanzees with non-A, non-B hepatitis. J Gen Virol 1989 0.90
40 Immunoperoxidase study of alkaline phosphatase in testicular tumor. Cancer 1981 0.90
41 Detection of HBsAg in the pancreas. Acta Pathol Jpn 1981 0.89
42 Detection of precore/core-mutant hepatitis B virus genome in patients with acute or fulminant hepatitis without serological markers for recent HBV infection. J Hepatol 1993 0.89
43 Variations of hepatitis B virus precore/core gene sequence in acute and fulminant hepatitis B. Dig Dis Sci 1994 0.89
44 Probable implication of mutations of the X open reading frame in the onset of fulminant hepatitis B. J Med Virol 1995 0.89
45 Non-A, non-B hepatitis related AN6520 Ag is a normal cellular protein mainly expressed in liver. II. J Med Virol 1986 0.89
46 Tissue distribution of human alpha1-microglobulin. J Clin Invest 1979 0.89
47 Geographical pathology of duck livers infected with duck hepatitis B virus from Chiba and Shimane in Japan and Shanghai in China. Cancer Res 1988 0.89
48 Peliosis hepatis. Report of nine cases. Acta Pathol Jpn 1979 0.89
49 Lack of susceptibility of various primates and woodchucks to hepatitis C virus. J Med Primatol 1994 0.89
50 Heterogeneity within the nonstructural protein 5-encoding region of hepatitis C viruses from a single patient. Gene 1992 0.88
51 "Silent" hepatitis B virus mutants are responsible for non-A, non-B, non-C, non-D, non-E hepatitis. Microbiol Immunol 1994 0.87
52 Interferon-inducible gene expression in chimpanzee liver infected with hepatitis C virus. Virology 1992 0.87
53 Seroconversion from hepatitis B e antigen to anti-HBe in acute hepatitis B virus infection. N Engl J Med 1978 0.86
54 Murine antibodies against E2 and hypervariable region 1 cross-reactively capture hepatitis C virus. Virology 1998 0.86
55 Murine humoral immune response against recombinant structural proteins of hepatitis C virus distinct from those of patients. Microbiol Immunol 1996 0.85
56 Isolation and sequence polymorphism of a rat retinoblastoma (RB) cDNA. Gene 1995 0.84
57 Gonadotropin and alkaline phosphatase producing occult gastric carcinoma with widespread metastasis of generalized bone. Cancer 1981 0.84
58 Polymyositis and toxoplasmosis. Acta Pathol Jpn 1981 0.84
59 A 6-year-old boy having hepatocellular carcinoma associated with hepatitis B surface antigenemia. Am J Clin Pathol 1980 0.84
60 Secretion and purification of hepatitis C virus NS1 glycoprotein produced by recombinant baculovirus-infected insect cells. Gene 1993 0.84
61 Enterically transmitted non-A, non-B hepatitis in cynomolgus monkeys: morphology and probable mechanism of hepatocellular necrosis. Liver 1989 0.84
62 A small epidemic of enterically transmitted non-A, non-B acute hepatitis. Gastroenterol Jpn 1991 0.84
63 Complete nucleotide sequences and the characteristics of two hepatitis B virus mutants causing serologically negative acute or chronic hepatitis B. J Med Virol 1995 0.84
64 Non-A, non-B hepatitis: visualization of virus-like particles from chimpanzee and human sera. Arch Virol 1989 0.83
65 Hepatocellular carcinoma. A clinical and pathologic analysis of 57 hepatectomy cases. Cancer 1983 0.83
66 Transmission of non-A, non-B hepatitis agent to chimpanzees from patients of epidemic hepatitis. Jpn J Med Sci Biol 1986 0.83
67 Two distinct types of hepatitis in experimental hepatitis B virus infection. Am J Pathol 1980 0.83
68 Immunohistochemical localization of nerve growth factor and epidermal growth factor in guinea pig prostate gland. Histochemistry 1984 0.83
69 Karyometric analysis of liver cell dysplasia and hepatocellular carcinoma. Evidence against precancerous nature of liver cell dysplasia. Cancer 1985 0.82
70 Cytoplasmic blood plasma inclusions of canine hepatocytes demonstration by immunoperoxidase-labeling method. Am J Vet Res 1980 0.82
71 Hepatocellular carcinoma and chronic persistent hepatitis. Acta Pathol Jpn 1977 0.81
72 A technique for successful 20 h kidney storage at 4 degrees C. Experientia 1965 0.81
73 Occurrence and ultrastructural localization of duck hepatitis B virus in the liver of ducks after experimental infection. Hepatology 1987 0.81
74 Simultaneous detection of thyroglobulin (Tg), thyroxine (T4), and Triiodothyronine (T3) in nontoxic thyroid tumors by the immunoperoxidase method. Am J Pathol 1982 0.80
75 Elastogenesis in the liver. Acta Pathol Jpn 1974 0.80
76 Localized hepatic necrosis related to cytomegalovirus and Toxoplasma gondii. Acta Pathol Jpn 1981 0.80
77 Detection of an antigen (AN6520), possibly related to non-A, non-B hepatitis, by monoclonal antibodies. I. J Med Virol 1986 0.80
78 In vitro transmission of duck hepatitis B virus to primary duck hepatocyte cultures. Hepatology 1988 0.80
79 Fulminant type A viral hepatitis in a chimpanzee. Acta Pathol Jpn 1982 0.80
80 Production of thyroxine (T4) and triiodothyronine (T3) in nontoxic thyroid tumors. An immunohistochemical study. Virchows Arch A Pathol Anat Histol 1981 0.80
81 Human hepatocellular carcinoma and putative precancerous disorders: their enzyme histochemical study. Arch Pathol Lab Med 1981 0.80
82 [Pathological, cytological and immunohistochemical study of normal-sized ovary carcinoma syndrome]. Rinsho Byori 2001 0.80
83 Immunoreactive core peptides of hepatitis C virus produced in Escherichia coli and in vitro DNA amplification-restricted transcription-translation system. J Virol Methods 1996 0.79
84 Biased sinusoidal field gel electrophoresis for the separation of large DNA. Electrophoresis 1993 0.79
85 Establishment and characterization of a woodchuck hepatocellular carcinoma cell line (WH44KA). Jpn J Cancer Res 1988 0.79
86 Defective copper binding to apo-ceruloplasmin in a rat model and patients with Wilson's disease. Liver 1995 0.79
87 Isolation and purification of a non-A, non-B hepatitis-associated microtubular aggregates protein. J Gen Virol 1990 0.79
88 Morphologic spectrum of liver diseases among chronic alcoholics. A comparison between Tokyo, Japan and Cincinnati, U.S.A. Acta Pathol Jpn 1980 0.79
89 Effect of 3'-azido-3'-deoxythymidine on replication of duck hepatitis B virus in vivo and in vitro. J Med Virol 1989 0.79
90 Reduced collagen biosynthesis in oral mucosa of beige (Chediak-Higashi) mice. Experientia 1985 0.79
91 Expression of pre-S1, pre-S2, S and X peptides in relation to viral replication in livers with chronic hepatitis B. Liver 1990 0.78
92 Experimental transmission of non-A, non-B hepatitis by saliva. J Infect Dis 1987 0.78
93 Establishment and characterization of a cisplatin-resistant human neuroblastoma cell line. Anticancer Res 2000 0.78
94 Prevention of hepatitis C virus infection in a chimpanzee by vaccination and epitope mapping of antiserum directed against hypervariable region 1. Hepatol Res 2001 0.78
95 Persistence of hepatitis B virus DNA after serological clearance of hepatitis B virus. Liver 1990 0.78
96 Frequent integration of hepatitis B virus DNA in noncancerous liver tissue from hepatocellular carcinoma patients. J Med Virol 1988 0.78
97 Increased expression of trk proto-oncogene by gamma-interferon in human neuroblastoma cell lines. Jpn J Cancer Res 1994 0.78
98 Inactivation of hepatitis C virus cDNA transgene by hypermethylation in transgenic mice. Arch Virol 1996 0.78
99 Comparison of amino acid sequences in hypervariable region-1 of hepatitis C virus clones between human inocula and the infected chimpanzee sera. Virus Res 1998 0.78
100 Influence of aflatoxin B1 intoxication on duck livers with duck hepatitis B virus infection. Cancer Res 1988 0.78
101 Analysis of 598 cases of neuroblastoma (NB) detected by screening and changes in the age distribution and incidence of NB patients after mass screening in infants in Japan. NB Screening Study Group. Prog Clin Biol Res 1994 0.78
102 Hepatitis E virus: cDNA cloning and expression. Microbiol Immunol 1992 0.78
103 AN6520 Ag: an antigen purified from liver with non-A, non-B hepatitis. J Med Virol 1985 0.78
104 Completely or nearly identical hepatitis B virus strains replicate between patients with acute or fulminant hepatitis B and their respective infectious sources. J Med Virol 1994 0.77
105 Immunoelectronmicroscopic study of alpha-fetoprotein synthesis in hepatoma cells. Ann N Y Acad Sci 1975 0.77
106 Pathology and pathogenesis of viral hepatitis. Southeast Asian J Trop Med Public Health 1978 0.77
107 Localization of woodchuck hepatitis virus in the liver. Hepatology 1988 0.77
108 HBV-associated ultrastructures in the chimpanzees' livers with experimental hepatitis B. Acta Pathol Jpn 1985 0.77
109 Blood pressure tracking in Japanese adolescents. Five-year follow-up in Hisayama, Japan. Jpn Heart J 1985 0.77
110 Detection of hepatitis C virus (HCV)-RNA in saliva and gastric juice. Adv Exp Med Biol 1995 0.77
111 Animal model, virology and gene cloning of hepatitis E. Gastroenterol Jpn 1991 0.77
112 An epidemic outbreak of hepatitis E in Yangon of Myanmar: antibody assay and animal transmission of the virus. Acta Pathol Jpn 1993 0.77
113 Immunoperoxidase staining of hepatitis C virus in formalin-fixed, paraffin-embedded needle liver biopsies. Virchows Arch 1994 0.77
114 Cloning and expression of cDNAs from enterically-transmitted non-A, non-B hepatitis virus. Microbiol Immunol 1991 0.77
115 Clonal state of human hepatocellular carcinoma and non-tumorous hepatocytes. Cancer Chemother Pharmacol 1989 0.76
116 Pathology of livers infected with "silent" hepatitis B virus mutant. Liver 1994 0.75
117 Relation between non-A, non-B and delta hepatitis: studies with monoclonal antibodies. Prog Clin Biol Res 1987 0.75
118 Organ specificity of the antigens reacting with the 48-1 and S-1 antibodies in chimpanzees infected with hepatitis C virus. Int J Exp Pathol 1991 0.75
119 Hepatitis C virus and liver diseases. Pathol Int 1994 0.75
120 [Epidemic non-A, non-B viral hepatitis--animal model and causative virus]. Nihon Rinsho 1988 0.75
121 [Autopsy study on disseminated herpes virus infection (author's transl)]. Rinsho Byori 1980 0.75
122 Leiomyosarcoma of the heart colliding with atrial myxoma. Acta Pathol Jpn 1981 0.75
123 Hepatitis C virus appears to replicate not only in hepatocytes but also in hepatocellular carcinoma cells as demonstrated by immunostaining. Pathol Int 1994 0.75
124 [Clinico-epidemiological study on obesity in relation to mortality figures. Twenty years follow-up results in Hisayama study]. Fukuoka Igaku Zasshi 1984 0.75
125 [Operative technic of renal transplantation]. Geka Chiryo 1967 0.75
126 [Symposium B. IV. The liver and allergy]. Arerugi 1969 0.75
127 [Epidemic non-A, non-B hepatitis in Okitsu area, Shimizu City (1980-1982)]. Nihon Rinsho 1991 0.75
128 [Ultrastructural study of non-A, non-B hepatitis by electron microscopy]. Nihon Rinsho 1988 0.75
129 Natural history of borderline hypertension in the Hisayama community, Japan--I. The relative prognostic importance of transient variability in blood pressure. J Chronic Dis 1984 0.75
130 [Pathology of toxic hepatitis]. Nihon Rinsho 1985 0.75
131 [Studies on non-A, non-B hepatitis: recent trends]. Nihon Rinsho 1987 0.75
132 [Discrepancy between liver function tests and biopsy findings--its fundamentals]. Nihon Rinsho 1967 0.75
133 [Development of chronic hepatitis and pathology of liver cirrhosis]. Naika 1969 0.75
134 [Comparison of liver lesions and liver function tests]. Rinsho Byori 1967 0.75
135 HBc and HBs antigen in hepatocytes. Gastroenterol Jpn 1975 0.75
136 [Effects of homologous and heterologous liver tissue with adjuvants on the regenerating liver]. Nihon Rinsho 1966 0.75
137 [Expression of hepatitis C virus genome]. Nihon Rinsho 1993 0.75
138 [Evaluation of intraperitoneal administration of polymyxin B sulfate]. Shujutsu 1968 0.75
139 [Morphologic characteristics of chronic hepatitis]. Nihon Rinsho 1966 0.75
140 [Non-A, non-B viral hepatitis]. Nihon Rinsho 1985 0.75
141 [Changes in blood chemical constituents and death in the aged population. The Hisayama Study]. Nihon Ronen Igakkai Zasshi 1986 0.75
142 [Animal model of non-A, non-B hepatitis infection]. Nihon Rinsho 1981 0.75
143 Phospholipid fatty liver: a proposal of a new concept and its electron microscopical study. Acta Pathol Jpn 1970 0.75
144 [Trends in studies of hepatitis A virus and the status of hepatitis A in Japan]. Nihon Rinsho 1977 0.75
145 [Progress on diagnosis and therapy of viral hepatitis]. Nihon Naika Gakkai Zasshi 1990 0.75
146 A preliminary serologic study of hepatitis A virus infection in Japan. Jpn J Med Sci Biol 1978 0.75
147 [Multiplication of elastic fibers in the liver]. Saishin Igaku 1969 0.75
148 Orcein-positive hepatocytes in hepatitis B: morphologic evidence of chronic hepatitis B virus infection? Arch Pathol Lab Med 1981 0.75
149 Evaluation of three hepatitis C virus-related antibodies C100, KCL-163, JCC. Tests for screening blood donors. Dig Dis Sci 1992 0.75
150 [Acute and chronic hepatic disorders]. Nihon Rinsho 1972 0.75
151 [Practice of intermittent peritoneal dialysis in surgery]. Geka Chiryo 1968 0.75
152 Efficacy of hepatitis B vaccine in chimpanzees given transfusions of highly infective blood. J Infect Dis 1983 0.75
153 [Blood chemical constituents as a risk factor in cerebral infarction. The Hisayama Study]. Nihon Ronen Igakkai Zasshi 1986 0.75
154 [A study of Alexander cell--especially production of alpha 1-microglobulin (author's transl)]. Nihon Shokakibyo Gakkai Zasshi 1980 0.75
155 Neuronal differentiation in human neuroblastoma cells by nerve growth factor following TrkA up-regulation by interferon-gamma. Med Pediatr Oncol 2000 0.75
156 [Trends in the studies of non-A, non-B hepatitis]. Nihon Rinsho 1981 0.75
157 [Immunohistological study of the localization of hepatitis B virus associated antigens in human pancreatic tissue (author's transl)]. Nihon Shokakibyo Gakkai Zasshi 1982 0.75
158 Effective production of mouse monoclonal antibodies against influenza virus by repeated intrasplenic immunization. Microbiol Immunol 1988 0.75
159 [Comparative study of MO, HA, and EIA methods for the detection of HBe-Ag and anti-HBe]. Rinsho Byori 1983 0.75
160 [Sample preparation for PCR from pathological specimens]. Nihon Rinsho 1992 0.75
161 [Intraperitoneal administration of erythromycin glucoheptonate and 5-methyl-3-sulfanilamidoisoxazole and peritoneal adhesion]. J Antibiot B 1967 0.75
162 Establishment of a new human chondrosarcomatous cell line. Acta Pathol Jpn 1979 0.75
163 [Isolation of a cDNA clone derived from variant type of hepatitis C virus]. Nihon Rinsho 1990 0.75
164 Occurrence of alpha-fetoprotein-containing hepatocytes in human embryos and fetuses: an immunohistochemical study using the light and ultrastructural immunoperoxidase methods. J Histochem Cytochem 1982 0.75
165 [HB antigen and liver diseases-pathological and immunopathological study (author's transl)]. Rinsho Byori 1975 0.75
166 Localization of hepatitis B surface antigen in the human parotid gland. Oral Surg Oral Med Oral Pathol 1985 0.75
167 Histological difference between complete responders and non-responders to interferon therapy of the livers of patients with chronic hepatitis C. Acta Pathol Jpn 1993 0.75
168 [Experience with 14 cases of kidney transplantation]. Naika 1967 0.75
169 [Clinical trial of hepatitis B vaccine in a high-risk population]. Nihon Shokakibyo Gakkai Zasshi 1983 0.75
170 Activities of serum acid ribonuclease in patients with malignant neoplasms or with renal failure. Clin Chim Acta 1983 0.75
171 Host resistance against tumor and cancer autografts in humans. Tohoku J Exp Med 1967 0.75
172 [Laboratory examination in PCBs poisoning patients with special reference to lipoprotein (author's transl)]. Fukuoka Igaku Zasshi 1981 0.75
173 Phospholipid fatty liver: a report of three cases with a new type of fatty liver. Jpn J Exp Med 1970 0.75
174 Blood grouping of chimpanzees by isoantibody. Nihon Juigaku Zasshi 1978 0.75
175 [Association of blood pressure and PCB levels in patients with polychlorinated biphenyl (PCB) poisoning]. Fukuoka Igaku Zasshi 1983 0.75
176 Immunoglobulin G and M hepatitis C virus core antibody (JCC.2) response in chimpanzees infected experimentally with hepatitis C virus. Intervirology 2000 0.75
177 [Analysis of the causes of failure in kidney transplantation]. Nihon Rinsho 1968 0.75
178 [Significance of HBe antigen in the experimental infection using chimpanzees]. Nihon Rinsho 1977 0.75
179 Ultrastructural changes of the bile secretory apparatus and bile ductule in experimental hepatitis B with neither apparent biochemical nor light-microscopic cholestasis. Acta Pathol Jpn 1985 0.75
180 [The prospect of non-A, non-B hepatitis research]. Nihon Rinsho 1988 0.75
181 Electron microscopy of ribonucleic acid in nuclear particulate aggregates of hepatitis D using nuclease-gold complexes. J Med Virol 1989 0.75
182 Oncogene expression in the liver tissue of patients with nonneoplastic liver disease. Cancer 1991 0.75
183 [Hepatocirrhosis in Japanese]. Naika 1971 0.75
184 [Electron microscopic study of the liver biopsy]. Rinsho Byori 1972 0.75
185 [Secondary phospholipidosis caused by 4.4'-diethylaminoethoxy hexestrol]. Rinsho Byori 1973 0.75
186 [Usefulness of HCV-ELISA using synthetic peptide]. Nihon Rinsho 1991 0.75
187 Identification of immune-complex deposition and T-lymphocyte in fulminant B-viral hepatitis with immunohistochemical techniques. Acta Pathol Jpn 1982 0.75
188 [Problems in kidney transplantation]. Saishin Igaku 1970 0.75
189 Necrosis of the hepatocytes with hepatitis B surface antigen. Occurrence in a chronic hepatitis B surface antigen carrier. Arch Pathol Lab Med 1977 0.75
190 Non-A, non-B hepatitis in experimentally infected chimpanzees with the NIH strains F and H. Acta Pathol Jpn 1982 0.75
191 [One staged renal transplantation]. Shujutsu 1967 0.75
192 Selective irradiation of lymph nodes with transitory ligation of the thoracic duct as an immunosuppressive measure in renal transplantation. Tohoku J Exp Med 1968 0.75
193 Lymphocytes in mice with membrane antigens common to human thymocytes. Adv Exp Med Biol 1982 0.75
194 Ultrastructural studies on liver cell necrosis and lymphocytes in experimental hepatitis B. Acta Pathol Jpn 1985 0.75
195 [Immunological study on stomach neoplasms using the fluorescent antibody technic]. Nihon Rinsho 1968 0.75
196 [An enzymeimmunoassay for the detection of HBe-Ag and anti-HBe]. Nihon Shokakibyo Gakkai Zasshi 1982 0.75
197 Safety and efficacy of hepatitis B vaccine in hospital personnel. Jpn J Med 1986 0.75
198 [Changes in various blood chemical constituents in relation to menopause. The Hisayama Study]. Nihon Ronen Igakkai Zasshi 1986 0.75
199 [Effects of antibiotics on the liver]. Nihon Rinsho 1966 0.75
200 Electron microscopical study of cytoplasmic inclusion body in hepatitis B. Jpn J Exp Med 1974 0.75
201 [Problems of kidney transplantation]. Geka Chiryo 1969 0.75
202 [Serum ribonuclease activity in the diagnosis of malignant neoplasms (author's transl)]. Nihon Naika Gakkai Zasshi 1982 0.75
203 [The activity of serum ribonuclease in pancreatic cancer]. Nihon Shokakibyo Gakkai Zasshi 1982 0.75
204 [Hepatitis B virus infection]. Shikai Tenbo 1985 0.75
205 Transplantation studies on human and duck hepatocytes in athymic nude mice. Liver 1991 0.75
206 Immunoperoxidase investigation of Regan isoenzyme of alkaline phosphatase in maxillary sinus carcinomas. Oral Surg Oral Med Oral Pathol 1986 0.75
207 Histopathological analysis of chronic hepatitis B virus (HBV) infection in relation to HBV replication. Liver 1987 0.75
208 [Sequences analysis of HCV variants by RT-PCR using mixed primers]. Nihon Rinsho 1991 0.75
209 Analysis of upstream region of hepatitis B virus core gene using in vitro transcription system. J Med Virol 1994 0.75
210 [Fulminant form of acute and sub-acute hepatitis: its concepts and pathogenesis]. Nihon Rinsho 1973 0.75
211 State of hepatitis B virus DNA in hepatocytes of patients with noncarcinomatous liver disease. Its special relationship with necroinflammatory activity and the stage of disease. Arch Pathol Lab Med 1989 0.75
212 [Histological localization of non-A, non-B hepatitis related antigen in the liver]. Nihon Rinsho 1988 0.75
213 Further studies of 48-1 antigen in serial liver biopsies from chimpanzees infected with hepatitis delta virus. J Med Virol 1990 0.75
214 In vitro transcription of the hepatitis B virus gene by nuclear extracts of human hepatoma cells. Virology 1991 0.75
215 Immunohistochemical localization of thyroxine (T4) and triiodothyronine (T3) in the rat thyroid gland under various experimental conditions. Acta Endocrinol (Copenh) 1983 0.75
216 [Present status of developing hepatitis C vaccines]. Nihon Naika Gakkai Zasshi 1994 0.75
217 [Rearing and management of chimpanzees for experimental infection with hepatitis B virus (author's transl)]. Jikken Dobutsu 1977 0.75
218 Analyses of amino acid sequences in hypervariable region-1 of hepatitis C virus (HCV) in sera from chimpanzees infected three times with the same HCV strain. J Med Primatol 2009 0.75
219 Liver morphology in marmosets infected with epidemic non-A, non-B hepatitis in India. Liver 1986 0.75
220 [Serum ribonuclease in patients with PCBs poisoning (author's transl)]. Fukuoka Igaku Zasshi 1979 0.75
221 The characteristics of alcoholic liver disease in Japan. Clinicopathologic comparison with alcoholic liver disease in the United States. Liver 1987 0.75
222 [HB antigen as a possible factor for causing hepatoma--a pathological viewpoint]. Nihon Rinsho 1974 0.75